FindTrial
Sign In

The anti-obesity effect of luteolin-prospective study

The anti-obesity effect of luteolin-prospective study - The anti-obesity effect of luteolin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034570
Enrollment
40
Registered
2018-10-19
Start date
2019-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

luteolin intake control

Sponsors

Department of cardilology, The university of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: BMI>22,patients who attend the university of Tokyo hospital

Exclusion criteria

Exclusion criteria: HD, diabetes, and cachexia.

Design outcomes

Primary

MeasureTime frame
BW,lipid,glucose,and insulin.—

Countries

Japan

Contacts

Public ContactATSUKO Nakayama

The university of Tokyo Department of cardilology

st7089-fki@umin.ac.jp+81338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026